Aurobindo Pharma Ltd has completed the acquisition of Generis Farmaceutica S.A. in Portugal.
In January this year, Hyderabad-based Aurobindo Pharma entered into an agreement entered into by Agile Pharma B.V., Netherlands, a wholly-owned step-down subsidiary of the company, to acquire 100 per cent shareholding in Generis Farmaceutica S.A for ₹969 crore (€135 million).
Generis is engaged in manufacture and marketing of pharmaceutical products in Portugal.
“All the formalities of and the process of acquisition have been completed on Friday,’’ the company informed the BSE today. As part of acquisition, Aurobindo got a manufacturing facility in Amadora, Portugal, which has the capacity to produce 1.2 billion tablets or capsules annually.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.